Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Tyrosinase Inhibitory Impact of Morus alba L. Root Bark: In Vitro and In Silico Studies.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • نبذة مختصرة :
      Background and objectives: The demand for skin care is a major concern, not only for women but also for men. Mulberry (Morus alba L.) is a medicinal plant widely used in traditional medicine, as well as for beauty and skin whitening. In this study, we investigated the inhibitory effect of Morus alba L. root bark extract on the enzyme tyrosinase. Methods: Mulberry root bark was extracted with ethanol (70%) at room temperature for 24 hours (repeated three times). The total ethanol extract was then suspended in water and successively partitioned with n-hexane, ethyl acetate and n-butanol. Tyrosinase enzyme inhibitory activity was determined spectrophotometrically at 475 nm. Additionally, we conducted a virtual screening of 60 compounds in mulberry roots to evaluate their inhibitory effects on tyrosinase enzyme. Results: Our results showed that the ethyl acetate fraction exhibited the highest tyrosinase enzyme inhibitory effect with the IC50 value of 12.68 ± 1.64 µg/mL, compared to kojic acid as the positive control (IC50 13.94 ± 0.30 µg/mL). Virtual screening identified 11 compounds were obtained with lower binding energies than two positive control compounds (kojic acid and arbutin). These compounds were evaluated for drug-like properties predicted pharmacokinetic-toxicological properties. Finally, two compounds, alfafuran and mulberroside C, which demonstrated the ability to inhibit the tyrosinase enzyme, were introduced. Conclusion: Our results indicated that the ethyl acetate fraction of Morus alba root bark extract has a strong inhibitory effects on the tyrosinase enzyme. [ABSTRACT FROM AUTHOR]
    • نبذة مختصرة :
      Copyright of Research Journal of Pharmacognosy (RJP) is the property of Research Journal of Pharmacognosy and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)